PHARMA - Relationships

Word 1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 1 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Co-occurrence Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Occurence-Centile Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Correlation Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Overlap-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	G-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►
Arthritis		Disease	Drug	Alefacept (Amevive)- FDA
Arthritis		Disease	Drug	Amevive (Alefacept)- FDA
Hypoglycemia		Disease	Target	CAMK2D
Seborrhea		Disease	Disease	Cradle Cap
Skin Disease		Disease	Drug	Alefacept (Amevive)- FDA
Skin Disease		Disease	Drug	Amevive (Alefacept)- FDA
Hyperthyroidism		Disease	Target	CAMK2B
Seizure		Disease	Target	CAMK2D
Diabetes		Disease	Drug	Alefacept (Amevive)- FDA
Diabetes		Disease	Drug	Amevive (Alefacept)- FDA
Dandruff		Disease	Disease	Cradle Cap
Hormone Replacement Therapy		Disease	Target	CAMK2D
Obesity		Disease	Target	AMY2B
Drug Abuse		Disease	Target	CAMK2B
Hearing Loss		Disease	Target	CAMK2B
Carcinoma		Disease	Target	AMY2B
Carcinoma		Disease	Target	CAMK1D
Carcinoma		Disease	Target	DJ-1/PARK7
Depression		Disease	Target	CAMK2D
Depression		Disease	Target	CAMK2B
Cancer		Disease	Drug	Alefacept (Amevive)- FDA
Cancer		Disease	Drug	Amevive (Alefacept)- FDA
Parkinsons Disease		Disease	Target	DJ-1/PARK7
Brain Injury		Disease	Target	CAMK2D
Parkinsonism		Disease	Target	DJ-1/PARK7
Ovarian Cancer		Disease	Target	AMY2B
Ovarian Cancer		Disease	Target	CAMK2D
Skin Cancer		Disease	Drug	Alefacept (Amevive)- FDA
Skin Cancer		Disease	Drug	Amevive (Alefacept)- FDA
Inflammatory Bowel Disease		Disease	Target	Protein Fimh
Infection		Disease	Target	CAMK2D
Stroke		Disease	Target	CAMK1D
Stroke		Disease	Target	CAMK2D
Influenza		Disease	Target	CAMK2B
Influenza		Disease	Target	Protein Fimh
Respiratory Tract Infections		Disease	Disease	Cradle Cap
Major Depressive Disorder		Disease	Target	CAMK2D
Cholesterol		Disease	Target	CAMK2B
Inflammation		Disease	Target	Protein Fimh
Anemia		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Cancer		Disease	Target	BRSK1
Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Cancer		Disease	Target	4-1BB Receptor
Carcinoma		Disease	Target	4-1BB Receptor
Cancer		Disease	Drug	Dracorhodin
Graft Versus Host Disease		Disease	Target	4-1BB Receptor
Cancer		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Arrhythmia		Disease	Drug	Apresoline (Hydralazine)- FDA
Prostate Cancer		Disease	Drug	Dracorhodin
Infection		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Diabetic Nephropathy		Disease	Drug	Dracorhodin
Myelodysplastic Syndrome		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Lung Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Scars		Disease	Drug	Dracorhodin
Diabetes		Disease	Target	BRSK1
Psychiatric Disorder		Disease	Target	Cyclooxygenase-3
Obesity		Disease	Target	BRSK1
Carcinoma		Disease	Target	BRSK1
Carcinoma		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Hemorrhage		Disease	Drug	Apresoline (Hydralazine)- FDA
Acute Promyelocytic Leukemia		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Stroke		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Glomerulonephritis		Disease	Drug	Apresoline (Hydralazine)- FDA
Renal Failure		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Anemia		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Cholesterol		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Hepatitis		Disease	Drug	Apresoline (Hydralazine)- FDA
Syphilis		Disease	Drug	Apresoline (Hydralazine)- FDA
Breast Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Lung Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Cancer		Disease	Target	Kallikrein-8
Infection		Disease	Target	Tegument Protein Vp16
Diarrhea		Disease	Drug	Amitiza (Lubiprostone)- FDA
Nausea		Disease	Drug	Amitiza (Lubiprostone)- FDA
Ovarian Cancer		Disease	Target	Kallikrein-8
Cancer		Disease	Drug	Aralen (Chloroquine)- FDA
Carcinoma		Disease	Target	Kallikrein-8
Cancer		Disease	Target	464.1
Infection		Disease	Target	Eotaxin-2/CCL24
Osteoporosis		Disease	Target	ALK Phos
Headache		Disease	Drug	Amitiza (Lubiprostone)- FDA
Colon Cancer		Disease	Target	Complement Decay-Accelerating Factor
Skin Disease		Disease	Target	Eotaxin-2/CCL24
Lung Cancer		Disease	Drug	Kaad-Cyclopamine
Lung Cancer		Disease	Target	Kallikrein-8
Non Small Cell Lung Cancer		Disease	Target	Kallikrein-8
Diabetes		Disease	Drug	Kaad-Cyclopamine
Diabetes		Disease	Target	464.1
Diabetes		Disease	Target	ALK Phos
Graft Versus Host Disease		Disease	Target	AMAC-1
Poisoning		Disease	Target	ALK Phos
Chronic Pain		Disease	Target	Mu-Type Opioid Receptor
Carcinoma		Disease	Target	464.1
Metastatic Breast Cancer		Disease	Drug	Aralen (Chloroquine)- FDA
Depression		Disease	Target	Mu-Type Opioid Receptor
Osteoarthritis		Disease	Target	ALK Phos
Osteoarthritis		Disease	Target	Kallikrein-8
Cancer		Disease	Target	ALK Phos
Cancer		Disease	Drug	Amitiza (Lubiprostone)- FDA
Prostate Cancer		Disease	Target	464.1